October 2026
Includes: AI-Powered Pathology Biomarker Predicts Survival, First commercial procedures performed with Zenflow Spring for BPH, Cancer’s ‘rogue DNA’,
Newly Diagnosed with Prostate Cancer: What to Expect in the First Few Weeks
Hearing the words “you have prostate cancer” can stop you in your tracks. Even if you suspected something was wrong, […]
Prostate Cancer and Mental Health
Daniel Munns MC, RCC is a Registered Clinical Counsellor with a Masters in Counselling. He joins Prostaid for a motivational unpacking of men’s mental health
September 2026
Includes: New drug combination may help treat advanced prostate cancer, Half of prostate cancer focal therapy use falls outside guideline-supported groups,
August 2026
Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,
Seeing and Striking the Target: How PSMA Is Transforming Prostate Cancer Care
Prostate cancer research in 2026 has been defined by a single molecule: PSMA, or prostate-specific membrane antigen. This protein sits […]
July 2026
Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,
Two New Approvals, One Clear Direction — Targeted Drug Therapies Come of Age in 2025
The past year brought two significant FDA approvals that signal where prostate cancer treatment is heading: toward more precise, earlier-acting […]
“Smart” Radiation Gets Smarter — Lutetium-177 Therapy Expands Its Reach
A treatment once reserved for men who had exhausted nearly every other option is now available earlier in the course […]
A New Standard in Detection — PSMA PET Imaging Is Changing How We Find Prostate Cancer
For decades, diagnosing and staging prostate cancer relied on a combination of CT scans, bone scans, and MRI. That picture […]